PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Clinical trial suggests combination therapy is best for low-grade brain tumors

2015-03-10
(Press-News.org) COLUMBUS, Ohio - New clinical-trial findings provide further evidence that combining chemotherapy with radiation therapy is the best treatment for people with a low-grade form of brain cancer. The findings come from a phase II study co-led by a researcher at Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) and researchers at the University of Maryland and at London Regional Cancer Program in Ontario, Canada. The study shows that patients with low-grade gliomas and at high risk for tumor recurrence have an overall survival of 73 percent after three years when treated with radiation plus temozolomide, a chemotherapy drug. This is compared with a three-year survival of 54 percent for historical controls treated with radiation alone. The findings are published in the International Journal of Radiation Oncology, Biology, Physics. "The most effective treatment for these rare tumors is currently controversial at best," says Arnab Chakravarti, MD, chair and professor of Radiation Oncology and co-director of the Brain Tumor Program at the OSUCCC - James. Chakravarti is the trial's translational research national study chair. "Many of these high-risk low-grade gliomas progress to grade III and IV tumors over time, so identifying the best treatment strategy is critical to ensure that patients have the best outcomes," says Chakravarti, who is also the Max Morehouse Chair in Cancer Research at Ohio State. "Our study reports that combining radiation with temozolomide-based chemotherapy appears to improve clinical outcome compared to historical controls treated by radiation alone. This may prove critical in killing enough tumor cells to prevent progression to stage IV disease, or glioblastoma multiforme, over time." Low-grade gliomas represent less than one percent of all human tumors in the United States. The average survival times vary depending on the tumor's structural, molecular and genetic features. (One form of high-risk low-grade glioma has an average overall survival of about 5 years.) The study's key technical findings include: The three-year progression-free survival rate was 59 percent. Grade 3 adverse events occurred in 43 percent of patients; grade 4 events occurred in 10 percent of patients. Chakravarti and his lab are currently conducting molecular studies to more specifically identify which low-grade glioma patients benefit from temozolomide.

INFORMATION:

Funding from the National Institutes of Health/National Cancer Institute (CA021661, CA037422, CA180868) supported this research. Other researchers involved in this study were Barbara J. Fisher, MD, and David R. Macdonald, MD, London Regional Cancer Program, Ontario, Canada; Chen Hu, PhD, Radiation Therapy Oncology Group-Statistical Center, Philadelphia; Glenn J. Lesser, MD, Wake Forest University; Stephen W. Coons, MD, Barrow Neurological Institute, Phoenix; David G. Brachman, MD, Arizona Oncology Services Foundation, Phoenix; Samuel Ryu, MD, Henry Ford Hospital, Detroit; Maria Werner-Wasik, MD, Thomas Jefferson University, Philadelphia; Jean-Paul Bahary, MD, Centre Hospitalier de l'Universite´ de Montre´al-Notre Dame, Montreal, Quebec, Canada; Junfeng Liu, PhD, GCE Solutions, Inc., Bloomington, Illinois; Minesh Mehta, MD, University of Maryland. The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only four centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State's cancer program as "exceptional," the highest rating given by NCI survey teams. As the cancer program's 306-bed adult patient-care component, The James is a "Top Hospital" as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S. News & World Report.



ELSE PRESS RELEASES FROM THIS DATE:

New carbon accounting method proposed

2015-03-10
Established ways of measuring carbon emissions can sometimes give misleading feedback on how national policies affect global emissions. In some cases, countries are even rewarded for policies that increase global emissions, and punished for policies that contribute to reducing them. "We have developed a new method that provides policy makers with more useful information, in order to set national targets and evaluate their climate policies", says Astrid Kander, Professor in Economic History at Lund University, and lead author of the study, published in the latest issue ...

Study reveals strong link between wildlife recreation and conservation

2015-03-10
What inspires people to support conservation? As concerns grow about the sustainability of modern society, this question becomes more important. A new study by a team of researchers from Clemson University and Cornell University offers one simple answer: birdwatching and hunting. Their survey of conservation activity among rural landowners in Upstate New York considered a range of possible predictors, such as gender, age, education, political ideology and beliefs about the environment. All other factors being equal, birdwatchers are about five times as likely, and hunters ...

Invertebrate palaeontology: The oldest crab larva yet found

2015-03-10
A study of a recently discovered fossil published by LMU zoologists reveals the specimen to be the oldest known crab larva: The fossil is 150 million years old, but looks astonishingly modern. To catch living crab larvae, all you have to do is trawl a plankton-net in the nearest bay or tidal pool. Finding fossilized crab larvae is rather more difficult - as witnessed by the fact that the specimen described in "Nature Communications" today by Ludwig-Maximilians-Universitaet (LMU) in Munich zoologists Joachim and Carolin Haug, and Joel Martin of the Natural History Museum ...

Small eddies produce global effects on climate change

2015-03-10
The increasing strength of winds over the Southern Ocean has extended its ability to absorb carbon dioxide, effectively delaying the impacts of global warming. New research published in the Journal of Physical Research found the intensifying wind over that ocean increased the speed and energy of eddies and jets, which are responsible in large part for the movement of nutrients, heat and salt across the ocean basin. The increased movement and overturning of these eddies and jets has accelerated the carbon cycle and driven more heat into the deep ocean. "Considering ...

DeuteRx's novel approach to chiral switching for racemic drugs

2015-03-10
ANDOVER, Mass. - March 9, 2015 - DeuteRx, LLC, is a research and development-focused biotechnology company dedicated to improving racemic small molecule marketed drugs and drug candidates intended for patients across multiple therapeutic indications. Today, DeuteRx announced the discovery of a method for the in vivo stabilization and differentiation of the individual enantiomers of selected thalidomide analogs. The method is described in The Proceedings of the National Academy of Science (PNAS), entitled: "Differentiation of antiinflammatory and antitumorigenic properties ...

CEO bonuses could cost companies in the long term

2015-03-10
Capping and regulating CEO payments, including performance bonuses, could help make companies more profitable in the long term, new research has found. According to modeling by Dr Peter Cebon at the University of Melbourne in Australia and Dr Benjamin Hermalin from the University of California, Berkeley, reliance on performance bonuses - which are often $7-10 AUD million per year for top Australian CEOs - can lead executives to pursue poor strategies, including being too focused on short term gains. The model also showed that if bonuses are restricted, CEOs and boards ...

Advances of alternating EM field for earthquake monitoring in China

2015-03-10
The paper summed the progress of the alternating EM field technique for earthquake monitoring and prediction after 1966 when Xingtai earthquake in Hebei province occurred, expounded the theoretical basement on electromagnetic field for this method, outlined new developed CSELF technique and the experimental examples and the study using satellite EM technologies, and introduced the new data processing and data mining techniques used for massive data (big data). The study, entitled "Advances in alternating electromagnetic field data processing for earthquake monitoring ...

High levels of vitamin D is suspected of increasing mortality rates

2015-03-10
The level of vitamin D in our blood should neither be too high nor to low. Scientists from the University of Copenhagen are the first in the world to show that there is a connection between high levels of vitamin D and cardiovascular deaths. In terms of public health, a lack of vitamin D has long been a focal point. Several studies have shown that too low levels can prove detrimental to our health. However, new research from the University of Copenhagen reveals, for the first time, that also too high levels of vitamin D in our blood is connected to an increased risk of ...

Solving the riddle of neutron stars

2015-03-10
This news release is available in German. It has not yet been possible to measure the gravitational waves predicted by Einstein's theory of general relativity. They are so weak that they get lost in the noise of the measurements. But thanks to the latest simulations of the merging of binary neutron star systems, the structure of the sought-after signals is now known. As a team of German and Japanese theoretical astrophysicists reports in the Editor's choice of the current edition of the scientific journal "Physical Review D", gravitational waves have a characteristic ...

Engineered cells could help tackle the third most common cancer in Chinese males

2015-03-10
Researchers at the University of Birmingham believe that a new method of genetically engineering immune cells could lead to improved treatment of Nasopharyngeal carcinoma (NPC) patients. The research, published in Cancer Immunology Research, explains how the team were able to create immune cells (T-cells) that use the presence of the Epstein-Barr virus to combat NPC. NPC develops in the upper part of the throat known as the nasopharynx, which connects the back of your nose to the back of your mouth. This particular cancer is unusually common throughout Southeast ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Clinical trial suggests combination therapy is best for low-grade brain tumors